Explore more
News
COVID, Moderna and FDA
Digest more
Moderna said on Friday it had filed a marketing application for an updated COVID vaccine to the U.S. Food and Drug ...
The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels ...
Moderna isn’t giving up on the combo shot entirely—it plans to resubmit later this year after it collects more data from its ...
Moderna on Thursday pushed back the time frame for likely approval of a combination vaccine meant to protect against both ...
Infectious disease experts say mRNA vaccines have been studied for decades, they are safe and effective, and were instrumental in saving lives during the COVID pandemic.
Moderna has withdrawn the Biologics License Application (BLA) for mRNA-1083, a combination vaccine against seasonal influenza and SARS-CoV-2, after ...
In terms of liquidity and interest, the mean open interest for Moderna options trades today is 1389.55 with a total volume of ...
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback